HartmutKoeppenMD

Hematopathology, Anatomic Pathology, Clinical Pathology

Physician

Dr. Koeppen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

1 citations
IL-27 elicits a cytotoxic CD8T cell program to enforce tumour control.
Béatrice Bréart, Katherine Williams, Stellanie Krimm, Tiffany Wong, Brandon D Kayser
Nature. 2025-03-01
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer.
Matthew D Galsky, Mark Kockx, Juliette Roels, Roos Van Elzen, Xiangnan Guan
Cancer Immunology Research. 2025-01-24
Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancers.
Brandon M Lehrich, Evan R Delgado, Tyler M Yasaka, Silvia Liu, Catherine Cao
Research Square. 2024-12-12

Journal Articles

Differential Regulation of PD-L1 Expression by Immune and Tumor Cells in NSCLC and the Response to Treatment with Atezolizumab (Anti–PD-L1)
Alan Sandler, David S Shames, Hartmut Koeppen, Jamie Chaft, Scott N Gettinger, Alexander Spira, Daniel S Chen, Naiyer A Rizvi, David R Spigel, Proceedings of the National Academy of Sciences

Abstracts/Posters

Pharmacodynamic Effects and Immune Correlates of Response to the CD20/CD3 Bispecific Antibody Mosunetuzumab in Relapsed or Refractory Non-Hodgkin Lymphoma
Hartmut Koeppen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019